G7 leaders prepare landmark statement to prevent future pandemics

Leaders kicked off a UK summit on Friday that will continue through Sunday, with the aim of coordinate the support and distribution of vaccines around the world, especially for the poorest countries.

After almost two years without a meeting, the heads of state and government of Germany, Canada, the United States, France, Italy, Japan and the United Kingdom returned to sit around a round table after the reception of the British Prime Minister Boris Johnson, host of the event in the seaside resort of Carbis Bay.

Leaders have set a target to distribute 1 billion doses of coronavirus vaccine and half of the doses will be donated by the United States, while the United Kingdom will deliver 100 million more.

While today, leaders will discuss global health with their counterparts from South Korea, South Africa, Australia and India, invited to the summit, in addition to the UN Secretary General, Antonio Guterres and heads of international organizations.

Conclusion

British scientist and government adviser, Patrick Vallance Yes Melinda French Gates will present the findings of the report prepared by the Pandemic Preparedness Association, a group of international experts from different sectors and formed earlier this year by the G7 to prevent, detect and respond to future pandemics.

The work, entitled “A 100-day mission to respond to future pandemic threats”, contains practical recommendations on how governments and others can respond quickly to any epidemic in the future.

The first 100 days after the identification of an epidemic threat is crucial to changing its course and, ideally, prevent it from becoming a pandemic.

The Carbis Bay statement, which will be released along with the summit communiqué, will also incorporate the recommendations of this report and set out other steps G7 countries will take to prevent a future pandemic.

According to scientists, 75% of new human diseases originate in animals.

To stop new zoonotic diseases before they put people at risk, the UK will establish a center for animal vaccine manufacturing and innovation at the Pirbright Institute in Surrey, southern England.